WuXi TIDES: difference between revisions

Diff·revision 24 → 25·13:37, 2 Nov 2024

Difference between revision 24 and revision 25 of WuXi TIDES. 8 lines changed; the page grew by 458 bytes.

Revision 24 — 18:41, 25 Oct 2024 COA_Colwyn (talk) ce 5,373 bytes +808	Revision 25 — 13:37, 2 Nov 2024 Chromatokid (talk) state the assay for the reference interval 5,831 bytes +458
30	Documentation practice is the most consistently described aspect of the organisation in reports reaching this wiki: shipments are reported to arrive with a batch-specific [[Certificate of analysis\|certificate]] naming a [[Batch number\|lot]], and the lot identifier on the certificate has generally matched the vial label in submitted material.{{r\|reports}} That correspondence is a minimum requirement rather than an achievement, but it fails often enough elsewhere in this sector to be worth recording.	30	Documentation practice is the most consistently described aspect of the organisation in reports reaching this wiki: shipments are reported to arrive with a batch-specific [[Certificate of analysis\|certificate]] naming a [[Batch number\|lot]], and the lot identifier on the certificate has generally matched the vial label in submitted material.{{r\|reports}} That correspondence is a minimum requirement rather than an achievement, but it fails often enough elsewhere in this sector to be worth recording.
31		31
+		32	== Product range ==
+		33	\| Class \| Representative listings \| Documentation reported \|
+		34	\|---\|---\|---\|
+		35	\| Incretin analogues \| Semaglutide, tirzepatide, retatrutide \| Batch certificate with HPLC trace \|
+		36	\| Research peptides \| BPC-157, TB-500, growth-hormone secretagogues \| Batch certificate \|
+		37	\| Oligonucleotides \| Custom synthesis, antisense constructs \| Certificate, sequence confirmation \|
+		38	\| SARMs and raw materials \| Bulk powders \| Certificate, variable detail \|
+		39
32	== References ==	40	== References ==
33	{{reflist}}	41	{{reflist}}